Skip to main content

Lionsgate Studios Corp. insider trading

LIONNYSE
$11.16-0.09 (-0.80%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+71.4%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • MHMark H. Rachesky M.D.Director12.6637%of company
  • JFJon FeltheimerChief Executive Officer1.4733%of company
  • MRMichael Raymond BurnsVice Chair1.093%of company
  • GCGordon CrawfordDirector0.7609%of company
  • JWJames W. BargeChief Financial Officer0.647%of company
  • BGBrian GoldsmithChief Operating Officer0.5827%of company
  • HSHarry SloanDirector0.1461%of company
  • BTBruce TobeyGeneral Counsel0.1416%of company
  • JDJohn D. Harkey Jr.Director0.0764%of company
  • YOYvette OstolazaDirector0.056%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
LIONMark H. Rachesky M.D.DirectorOpen market purchaseNot reported+58464.3%Not reportedNot reportedJul 8, 2026Jul 10, 2026
LIONMark H. Rachesky M.D.DirectorOpen market sellNot reported-74.3%Not reportedNot reportedJul 8, 2026Jul 10, 2026
LIONMark H. Rachesky M.D.DirectorOpen market purchaseNot reported+78604.1%Not reportedNot reportedJul 8, 2026Jul 10, 2026
LIONMark H. Rachesky M.D.DirectorOpen market purchaseNot reported+2485.5%Not reportedNot reportedJul 8, 2026Jul 10, 2026
LIONMark H. Rachesky M.D.DirectorOpen market sellNot reported-72.2%Not reportedNot reportedJul 8, 2026Jul 10, 2026
LIONMark H. Rachesky M.D.DirectorOpen market purchaseNot reported+3341.7%Not reportedNot reportedJul 8, 2026Jul 10, 2026
LIONMark H. Rachesky M.D.DirectorOpen market purchaseNot reported+55476.6%Not reportedNot reportedJul 8, 2026Jul 10, 2026
LIONMark H. Rachesky M.D.DirectorOpen market purchaseNot reported+9530.4%Not reportedNot reportedJul 8, 2026Jul 10, 2026
LIONMark H. Rachesky M.D.DirectorOpen market purchaseNot reported+3966.4%Not reportedNot reportedJul 8, 2026Jul 10, 2026
LIONMark H. Rachesky M.D.DirectorOpen market sellNot reported-99.9%Not reportedNot reportedJul 8, 2026Jul 10, 2026
LIONMark H. Rachesky M.D.DirectorOpen market sellNot reported-99.5%Not reportedNot reportedJul 8, 2026Jul 10, 2026
LIONMark H. Rachesky M.D.DirectorOpen market sellNot reported-98.7%Not reportedNot reportedJul 8, 2026Jul 10, 2026
LIONMichael Raymond BurnsVice ChairOpen market sell$196K-0.7%$9.01$196KDec 23, 2025Dec 29, 2025
LIONJon FeltheimerChief Executive OfficerOpen market sell$1.61M-5.3%$8.28$1.61MDec 22, 2025Dec 29, 2025
LIONBrian GoldsmithChief Operating OfficerOpen market sell$214K-1.7%$8.54$214KDec 18, 2025Dec 19, 2025
End of history · 15 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.